Vector Science & Therapeutics Builds 15-Patent-Application Intellectual Property Portfolio Around Precision Therapeutic Delivery, Anchored by Peptide and Biologic Administration Technologies

Company's expanding IP estate is led by multiple pending applications in peptide and biologic delivery, alongside advanced drug delivery, opioid-sparing pain management, pancreatic oncology, regenerative medicine and smart wound care MEQUON, Wis., July 15, 2026 /PRNewswire/ -- Vector...

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.